Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome.

Weerts ZZRM, Vork L, Mujagic Z, Keszthelyi D, Hesselink MAM, Kruimel J, Leue C, Muris JWM, Jonkers DMAE, Masclee AAM.

Neurogastroenterol Motil. 2019 May 22:e13629. doi: 10.1111/nmo.13629. [Epub ahead of print]

PMID:
31119844
2.

The Experience Sampling Method-Evaluation of treatment effect of escitalopram in IBS with comorbid panic disorder.

Vork L, Mujagic Z, Drukker M, Keszthelyi D, Conchillo JM, Hesselink MAM, van Os J, Masclee AAM, Leue C, Kruimel JW.

Neurogastroenterol Motil. 2019 Jan;31(1):e13515. doi: 10.1111/nmo.13515. Epub 2018 Nov 20.

PMID:
30460734
3.

Development of a real-time patient-reported outcome measure for symptom assessment in patients with functional dyspepsia using the experience sampling method.

Smeets FGM, Keszthelyi D, Vork L, Tack J, Talley NJ, Simren M, Aziz Q, Ford AC, Conchillo JM, Kruimel JW, Van Os J, Masclee AAM.

Neurogastroenterol Motil. 2019 Feb;31(2):e13496. doi: 10.1111/nmo.13496. Epub 2018 Nov 4.

PMID:
30393939
4.

A Novel Ileocolonic Release Peppermint Oil Capsule for Treatment of Irritable Bowel Syndrome: A Phase I Study in Healthy Volunteers.

Weerts ZZRM, Keszthelyi D, Vork L, Aendekerk NCP, Frijlink HW, Brouwers JRBJ, Neef C, Jonkers DMAE, Masclee AAM.

Adv Ther. 2018 Nov;35(11):1965-1978. doi: 10.1007/s12325-018-0802-1. Epub 2018 Oct 4.

PMID:
30284674
5.

The development of a patient-reported outcome measure for real-time symptom assessment in a population with functional urologic complaints-A focus group study.

Herrewegh A, Vork L, Eurelings E, Leue C, Kruimel J, van Koeveringe G, Vrijens D.

Neurourol Urodyn. 2018 Nov;37(8):2893-2903. doi: 10.1002/nau.23808. Epub 2018 Sep 6.

PMID:
30187953
6.

Development, content validity, and cross-cultural adaptation of a patient-reported outcome measure for real-time symptom assessment in irritable bowel syndrome.

Vork L, Keszthelyi D, Mujagic Z, Kruimel JW, Leue C, Pontén I, Törnblom H, Simrén M, Albu-Soda A, Aziz Q, Corsetti M, Holvoet L, Tack J, Rao SS, van Os J, Quetglas EG, Drossman DA, Masclee AAM.

Neurogastroenterol Motil. 2018 Mar;30(3). doi: 10.1111/nmo.13244. Epub 2017 Nov 6.

PMID:
29106029
7.

Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.

Vork L, Weerts ZZRM, Mujagic Z, Kruimel JW, Hesselink MAM, Muris JWM, Keszthelyi D, Jonkers DMAE, Masclee AAM.

Neurogastroenterol Motil. 2018 Feb;30(2). doi: 10.1111/nmo.13189. Epub 2017 Aug 14.

PMID:
28804974
8.

Gastrointestinal disorders in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type: A review for the gastroenterologist.

Beckers AB, Keszthelyi D, Fikree A, Vork L, Masclee A, Farmer AD, Aziz Q.

Neurogastroenterol Motil. 2017 Aug;29(8). doi: 10.1111/nmo.13013. Epub 2017 Jan 13. Review.

PMID:
28086259
9.

Proton pump inhibitors affect the gut microbiome.

Imhann F, Bonder MJ, Vich Vila A, Fu J, Mujagic Z, Vork L, Tigchelaar EF, Jankipersadsing SA, Cenit MC, Harmsen HJ, Dijkstra G, Franke L, Xavier RJ, Jonkers D, Wijmenga C, Weersma RK, Zhernakova A.

Gut. 2016 May;65(5):740-8. doi: 10.1136/gutjnl-2015-310376. Epub 2015 Dec 9.

10.

The Experience Sampling Method--a new digital tool for momentary symptom assessment in IBS: an exploratory study.

Mujagic Z, Leue C, Vork L, Lousberg R, Jonkers DM, Keszthelyi D, Hesselink MA, van Schagen TJ, van Os J, Masclee AA, Kruimel JW.

Neurogastroenterol Motil. 2015 Sep;27(9):1295-302. doi: 10.1111/nmo.12624. Epub 2015 Jun 22.

PMID:
26100684

Supplemental Content

Support Center